Study S003313

A Mass Balance Study of 14C-RAY1225 Injection in Healthy Chinese Participants

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07460284
Study type: INTERVENTIONAL
Phase: PHASE1
Masking: NONE
Status: NOT_YET_RECRUITING
Enrollment: 8
Start: 2026-03-15
Primary completion: 2026-10-14
Lead sponsor: Guangdong Raynovent Biotech Co., Ltd
Conditions: Basic Science
Interventions: DRUG:14C-RAY1225
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Total radioactivity recovery and cumulative recovery in urine and feces in each time period; [DAY1~DAY60]
Radioactivity of each metabolite in urine and feces as a percentage of the total administered dose and the circulating metabolites in plasma as a percentage of the total exposure AUC (%AUC); [DAY1~DAY60]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.